Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Stefan Pscherer; Eva Susanne Dietrich; Franz-Werner Dippel; Aileen Rae Neilson

doi:10.3205/000106

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Stefan Pscherer, Eva Susanne Dietrich, Franz-Werner Dippel, Aileen Rae Neilson

Centre for Reviews and Dissemination

Research output: Contribution to journal › Article › peer-review

Abstract

To compare the treatment costs of insulin glargine (IG; Lantus) to detemir (ID; Levemir), both combined with bolus insulin aspart (NovoRapid) in type 2 diabetes (T2D) in Germany.

Original language	English
Journal	German medical science : GMS e-journal
Volume	8
DOIs	https://doi.org/10.3205/000106
Publication status	Published - 2010

Access to Document

10.3205/000106

Cite this

@article{5a1dc9fee54a47b2a896a769d9c17566,

title = "Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany",

abstract = "To compare the treatment costs of insulin glargine (IG; Lantus) to detemir (ID; Levemir), both combined with bolus insulin aspart (NovoRapid) in type 2 diabetes (T2D) in Germany.",

author = "Stefan Pscherer and Dietrich, {Eva Susanne} and Franz-Werner Dippel and Neilson, {Aileen Rae}",

year = "2010",

doi = "10.3205/000106",

language = "English",

volume = "8",

journal = "German medical science : GMS e-journal",

issn = "1612-3174",

publisher = "German Medical Science",

}

TY - JOUR

T1 - Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

AU - Pscherer, Stefan

AU - Dietrich, Eva Susanne

AU - Dippel, Franz-Werner

AU - Neilson, Aileen Rae

PY - 2010

Y1 - 2010

N2 - To compare the treatment costs of insulin glargine (IG; Lantus) to detemir (ID; Levemir), both combined with bolus insulin aspart (NovoRapid) in type 2 diabetes (T2D) in Germany.

AB - To compare the treatment costs of insulin glargine (IG; Lantus) to detemir (ID; Levemir), both combined with bolus insulin aspart (NovoRapid) in type 2 diabetes (T2D) in Germany.

UR - http://www.scopus.com/inward/record.url?scp=77957277794&partnerID=8YFLogxK

U2 - 10.3205/000106

DO - 10.3205/000106

M3 - Article

C2 - 20725588

SN - 1612-3174

VL - 8

JO - German medical science : GMS e-journal

JF - German medical science : GMS e-journal

ER -

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Abstract

Access to Document

Other files and links

Cite this